324 filings
Page 4 of 17
8-K
w87hfb
17 Aug 21
Brooklyn ImmunoTherapeutics Announces Second Quarter 2021 Financial Results
5:29pm
8-K
bga4r0mer 3c
19 Jul 21
Departure of Directors or Certain Officers
5:29pm
8-K
wjx313g446t9zej
19 Jul 21
Brooklyn ImmunoTherapeutics Completes Acquisition of Novellus Therapeutics
4:05pm
8-K
eb7l1 qhegd90jky
21 Jun 21
Departure of Directors or Certain Officers
5:00pm
8-K
1j5hs
14 Jun 21
Other Events
5:00pm
8-K
pkgvw943 4wlgezjn71
10 Jun 21
Departure of Directors or Certain Officers
5:20pm
8-K
shdl8jwg3 hw
26 May 21
Entry into a Material Definitive Agreement
5:20pm
8-K
xjf05vj80
11 May 21
Departure of Directors or Certain Officers
5:25pm
8-K/A
uyon2e
30 Apr 21
Financial Statements and Exhibits
5:11pm
8-K
cvlzja0nl got
30 Apr 21
Entry into a Material Definitive Agreement
4:11pm
8-K
7n28o7ujvo21
23 Apr 21
Changes in Registrant's Certifying Accountant
5:20pm
8-K
4spkz
16 Apr 21
Departure of Directors or Certain Officers
5:20pm
8-K
bmmbtsbt7a4e2hq
15 Apr 21
Entry into a Material Definitive Agreement
5:20pm
8-K
bryv mu24sexxcr7
7 Apr 21
Entry into a Material Definitive Agreement
5:18pm
8-K
k8gvkc 6m
31 Mar 21
Completion of Acquisition or Disposition of Assets
5:18pm
8-K
rgv apnqnyc0b
23 Mar 21
NTN Buzztime Announces Proposed Reverse Stock Split Ratio and Anticipated Closing of Merger
5:28pm
8-K
s8biblicu44smwqr
16 Mar 21
NTN Buzztime Announces Approval of Merger with Brooklyn Immunotherapeutics by Stockholders at Special Meeting
12:00am
8-K
213b64ru
8 Mar 21
Independent Advisory Firm ISS Recommends NTN Stockholders Vote FOR Proposed Merger and Asset Sale and ALL Related Proposals
7:07am
8-K
7sqaxeewbyve
26 Feb 21
Other Events
4:32pm
8-K
5itomy6v
25 Feb 21
Other Events
7:02am